Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

New Delivery Mechanism for MS Drug

October 15, 2010 8:06 am | News | Comments

Merck KGaA announced the upcoming introduction of the new device RebiDose, the Rebif single use pre-filled pen, for the self-administration of Rebif (interferon beta-1a), a disease-modifying drug used to treat relapsing forms of multiple sclerosis.


Study Uncovers a New Gene for Memory

October 15, 2010 7:56 am | News | Comments

Researchers have identified a new gene that is required for memory formation in Drosophila, the common fruit fly. The gene may have similar functions in humans, shedding light on neurological disorders such as Alzheimer’s disease.


Rewiring a Damaged Brain

October 15, 2010 7:50 am | News | Comments

Researchers are developing microelectronic circuitry to guide the growth of axons in a brain damaged by an exploding bomb, car crash, or stroke. The goal is to rewire the brain connectivity and bypass the region damaged by trauma.


Inflammation Causes Some Postsurgical Neuropathies

October 15, 2010 7:48 am | News | Comments

A new study has found that nerve inflammation may cause the pain, numbness, and weakness following surgical procedures. Known as postsurgical neuropathy, it has typically been attributed to compression or stretching of nerves during surgery.


Study Identifies Genetic Risk Factor for ALS

October 15, 2010 7:44 am | News | Comments

A study led by researchers from the University of Pennsylvania has identified a new genetic risk factor for amyotrophic lateral sclerosis (ALS) or Lou Gehrig’s disease.


Warning Letters Sent to Eight Companies

October 15, 2010 7:32 am | by Matthew Perrone | News | Comments

The Food and Drug Administration warned eight companies to stop marketing miracle cures that claim to treat everything from autism to Parkinson's disease by flushing toxic metals from the body.


Leishmanisis Outbreak Effects Thousands

October 15, 2010 7:30 am | by Robert Kennedy | News | Comments

An outbreak of a tropical disease caused by sand fly bites that leaves disfiguring skin sores has hit Afghanistan, with tens of thousands of people infected, health officials said.


FDA Apologizes for Erroneous Approval

October 15, 2010 7:26 am | by Matthew Perrone | News | Comments

Almost two years ago, the Food and Drug Administration ignored the advice of its scientists and approved a knee implant after being lobbied by members of Congress. The agency has now issued an unprecedented "mea culpa," saying the device should not have been approved.


CVS Fined $75M for Meth Failures

October 15, 2010 7:20 am | by Greg Risling | News | Comments

In order to comply with federal drug regulations, CVS Pharmacy Inc. employed a new automated system three years ago to keep tabs on the sale of one of methamphetamine's main ingredients, pseudoephedrine. The program known as "Meth Tracker" had one glaring flaw, however.


States Linking Prescription Databases

October 15, 2010 7:16 am | News | Comments

Starting next year, dozens of states will begin knitting together databases to watch prescription drug abuse, from powerful painkillers to diet pills.


The Search for CNS Cures

October 14, 2010 12:58 pm | Digital Editions | Comments

Advances in medicine and healthcare are helping people live longer. However, healthcare systems and governments may not be prepared to deal with the medical, economic, and social challenges of an aging population.


Automated Filling Station

October 14, 2010 8:28 am | Drug Discovery & Development | Product Releases | Comments

Watson-Marlow offers its Flexicon FPC50W, an operator-friendly, fully-automated filling and plugging system that offers accuracy, flexibility for aseptic filling, capping in clinical trials and scale-up applications.


Fragmentation Kit

October 14, 2010 8:22 am | Drug Discovery & Development | Product Releases | Comments

These kits are designed for the generation and isolation of Fab and F(ab)2 fragments from immunoglobulin G (IgG). Utilizing G-Biosciences’ Immobilized Papain and Immobilized Pepsin, these enzymes cleave IgG near the hinge region to segregate Fab and F(ab)2 molecules.


Novartis Signs Agreement With Synthetic Genomics

October 14, 2010 8:09 am | News | Comments

Novartis announced an agreement with Synthetic Genomics Vaccines Inc. to apply "synthetic genomics" technologies to accelerate the production of the influenza seed strains required for vaccine manufacturing.


Roche Sales Down 7% for Quarter

October 14, 2010 8:04 am | News | Comments

Pharmaceuticals maker Roche Holding AG reported its third quarter sales dropped 7 percent on lower demand for its antiviral Tamiflu. Sales have dropped almost a billion dollars since a year ago.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.